Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.
about
Risperidone (depot) for schizophreniaThe role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.Adverse effects associated with second-generation antipsychotic long-acting injection treatment: a comprehensive systematic review.Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoateOptimizing outcomes in schizophrenia: long-acting depots and long-term treatment.Long-acting injectable formulations of new-generation antipsychotics: a review from a clinical perspective.Weight gain and antipsychotics: a drug safety review.Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal.Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.Understanding depot antipsychotics: an illustrated guide to kinetics.Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications.
P2860
Q24185901-43871F6B-D0F6-4017-B6E8-3BECEDE4BBDAQ34418847-3DEBB2CA-AF8D-4392-AD3E-1BE1089B1713Q34436401-41FB9C7C-2259-48F3-852E-4071C2D9A49EQ34775426-93B2C775-BB27-4D1E-BF49-4E07C24D5CEBQ36568895-1419ED5F-75F3-42DD-BF0B-EE3565520D45Q38086645-AFCE020B-9804-4ACB-AD0A-D3D4AC858839Q38115487-F0C43529-AE19-4FF3-BFE6-F9878AF35DD5Q38268590-2CFF3AA0-4AD0-45D2-87FB-C25ED5E708DEQ38473914-DC39402B-57AF-42D8-B6D4-F314DAA51173Q38659006-E03F4043-8D17-4441-9597-5D326D067AC2Q41828437-D8BB236A-E148-427B-A138-25B570B9FDCCQ45769368-6BD66484-077F-43D9-B902-EC84288B1C15Q47958009-7EF290E6-2965-48BF-BDE9-773B706296CAQ50541514-C753A794-4320-4BD7-9291-730CDB8B437EQ51202982-2A11460D-0622-4D68-BF00-A333CBD2E048
P2860
Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effectiveness of switching fro ...... , randomized controlled trial.
@ast
Effectiveness of switching fro ...... , randomized controlled trial.
@en
type
label
Effectiveness of switching fro ...... , randomized controlled trial.
@ast
Effectiveness of switching fro ...... , randomized controlled trial.
@en
prefLabel
Effectiveness of switching fro ...... , randomized controlled trial.
@ast
Effectiveness of switching fro ...... , randomized controlled trial.
@en
P2093
P2860
P356
P1476
Effectiveness of switching fro ...... l, randomized controlled trial
@en
P2093
Carlos T Jackson
Ingrid A Rojas
Joseph P McEvoy
Nancy H Covell
Nina R Schooler
Schizophrenia Trials Network
Susan M Essock
P2860
P304
P356
10.4088/JCP.11M07074
P50
P577
2012-03-06T00:00:00Z